Classes
Publications
- Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer2019 | First Faculty of Medicine
- Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer2019 | First Faculty of Medicine
- Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer +12018 | First Faculty of Medicine, Second Faculty of Medicine
- Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer2018 | First Faculty of Medicine
- Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes2018 | First Faculty of Medicine
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study2018 | First Faculty of Medicine
- Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls2018 | First Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine
Loading network view...
